VKH
ONSIZ

Virtu KCG Holdings’s Oncobiologics, Inc. Series B Warrant ONSIZ Stock Holding History

Virtu KCG Holdings’s Portfolio ONSIZ Stock Details ONSIZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$1K Buy
+11,304
New +$2.06K ﹤0.01% 2816

Other funds holding ONSIZ

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu KCG Holdings's ONSIZ Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Oncobiologics, Inc. Series B Warrant (ONSIZ) in Q2 2017: 11,304 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2816 among its holdings.

12 funds tracked by Wall St. Rank hold ONSIZ as of Q2 2017.

  • Virtu KCG Holdings held 11,304 shares of Oncobiologics, Inc. Series B Warrant worth $1K as of Q2 2017.
  • Oncobiologics, Inc. Series B Warrant was a new Virtu KCG Holdings position in Q2 2017.
  • Oncobiologics, Inc. Series B Warrant made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2816 holding.
  • 12 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series B Warrant as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.